Table 63 (abstract A1028). Demographic and Clinical Features
Total Cohort (n = 439) | Blood Culture + ve (n = 56) | Blood Culture -ve (n = 383) | p value | PCR/ESI-MS + ve (n = 177) | PCR/ESI-MS -ve (n = 262) | p value | |
|---|---|---|---|---|---|---|---|
Median Age (yrs) median (IQR) | 65(49–75) | 64(48–71) | 66(50–76) | 0.2 | 66(54–78) | 64(46–72) | 0.01 |
Sex (m%) | 66 % | 69 % | 63 % | 0.2 | 64 % | 66 % | 0.9 |
Antimicrobial use within 30 days preceding hospital | 11 % | 9 % | 12 % | 0.8 | 10 % | 12 % | 0.9 |
Antimicrobial use in hospital but preceding study enrolment | 59 % | 57 % | 60 % | 0.8 | 58 % | 60 % | 0.6 |
SOFA score on enrolment (median/IQR) | 7(4–11) | 10(6–12) | 7(4–11) | 0.01 | 8(5–11) | 7(4–10) | 0.005 |
Vasopressor use on enrolment | 55 % | 68 % | 53 % | 0.04 | 62 % | 50 % | 0.02 |
Requirement for mechanical ventilation | 59 % | 54 % | 59 % | 0.5 | 66 % | 54 % | 0.02 |
Pre-existing Diabetes | 24 % | 27 % | 23 % | 0.6 | 24 % | 23 % | 0.8 |
Pre-existing Cancer | 29 % | 30 % | 29 % | 0.9 | 34 % | 26 % | 0.09 |